Cande, Nenita L.
HRN: 00-81-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/18/2023
IV
2g
Q12 Hours
CAP-MR; Presumptive PTB; T/c TB Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes